Compare Johnson & Johnson (JNJ) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Zoom Video Communications, Inc. — how do they compare? Johnson & Johnson trades at $248.49 (market cap $598.96B), while Zoom Video Communications, Inc. trades at $90.05 (market cap $26.66B). The key difference: Johnson & Johnson is far larger — about 22.5× Zoom Video Communications, Inc.'s market cap, and Johnson & Johnson pays a 2.15% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| JNJ | ZM | |
|---|---|---|
Market Cap | $598.96B | $26.66B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $111.88 |
52-Week Low | $164.36 | $69.77 |
Enterprise Value | $631.90B | $19.00B |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
Zoom Communications (ZM) trades at $91.04, down 0.1% on the day, with a bullish technical signal from moving averages and support at $90. The company reported Q1 2026 EPS of $1.55, beating expectations, and maintains strong profitability with a net income margin of 42.0%. Recent news highlights AI product launches and a $1 billion buyback authorization, while analyst consensus price target sits at $118.79.
The outlook for ZM is cautiously optimistic, with upside potential driven by AI integration and solid cash flow, but risks include competitive pressure from Microsoft and Google, insider selling, and fluctuating cash flow trends. Wall Street sentiment is mixed, with 39% of analysts rating it Buy amid moderate growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
